ORX750A Study of ORX750 in Participants With Narcolepsy and Idiopathic Hypersomnia

Sponsor:

Centessa Pharmaceuticals (UK) Limited

Code:

NCT06752668

Conditions

Narcolepsy Type 1

Narcolepsy Type 2

Idiopathic Hypersomnia

Eligibility Criteria

Sex: All

Age: 18 - 65

Healthy Volunteers: Not accepted

Interventions

ORX750

Placebo

Study Details

Eligibility Criteria

Study Design

Interventions and Outcome Measures

Central Contacts and Locations

More Information

Trial information was received from ClinicalTrials.gov and was last updated on 2026-08-26. This information was provided to ClinicalTrials.gov by Centessa Pharmaceuticals (UK) Limited on 2026-04-27.